Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06107192 · ClinicalTrials.gov registry record · NA
Gut Microbial Metabolites of Apple Polyphenols
A NA study, sponsored by University of Maryland, College Park.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT06107192: Completed NA study, sponsored by University of Maryland, College Park.
NCT06107192 is a NA study that has completed, run by University of Maryland, College Park. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06107192, a NA study, has completed, sponsored by University of Maryland, College Park.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The goal of this controlled feeding trial is to learn about the metabolism of polyphenols, a common class of compounds found in plant-based foods, by the gut microbiome. It will evaluate how differences in gut bacteria across individuals influence metabolism of polyphenols from foods, which may influence health benefits that people receive from different foods.
Primary Outcome
Mean difference in sum catechin metabolite concentration in response to the intervention, stratified by ODMA producers and non-producers.
Interventions
- OTHER Dietary intervention - apple catechin diet
- OTHER Dietary intervention - low catechin diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2023-12-07 |
| Est. Completion | 2025-05-08 |
| Phase | NA |
What the finished NCT06107192 record still lists
NCT06107192 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Dietary intervention - apple catechin diet is the first listed.
NCT06107192 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06107192 about?
NCT06107192 is a clinical study titled "Gut Microbial Metabolites of Apple Polyphenols". The goal of this controlled feeding trial is to learn about the metabolism of polyphenols, a common class of compounds found in plant-based foods, by the gut microbiome. It will evaluate how differences in gut bacteria across individuals influence metabolism of polyphenols from foods, which may infl...
What is the current status of trial NCT06107192?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2023-12-07. Estimated completion is 2025-05-08.
What interventions are being tested in trial NCT06107192?
The interventions under investigation include: Dietary intervention - apple catechin diet (OTHER), Dietary intervention - low catechin diet (OTHER).
Who is sponsoring clinical trial NCT06107192?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06107192's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI